Cell viability was assessed in both human (SJ-GBM2 mIDH1) and murine glioma (mIDH1 NPAI, mIDH1 CPAI, and mIDH1 RPAI) cells treated with ATG9b siRNAs, both in the presence and absence of IR. The gene discussed is ATG9B; the disease is central nervous system cancer.